4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000006
PRESIDENT AND COO sold 14,625 shares at an average $464.66 ($6,795,627)
- PRESIDENT AND COO acquired 14,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-20 | Exercise or conversion : show line 1 in the form 10b5-1 | −14,625 | $117.76 | $1,722,240 | 14,625 | I |
| 2026-01-20 | Sale : show line 2 in the form 10b5-1 | −116 | $456.87 | $52,996 | 14,509 | I |
| 2026-01-20 | Sale : show line 3 in the form 10b5-1 | −692 | $457.92 | $316,879 | 13,817 | I |
| 2026-01-20 | Sale : show line 4 in the form 10b5-1 | −700 | $458.74 | $321,116 | 13,117 | I |
| 2026-01-20 | Sale : show line 5 in the form 10b5-1 | −498 | $459.87 | $229,013 | 12,619 | I |
| 2026-01-20 | Sale : show line 6 in the form 10b5-1 | −503 | $461.12 | $231,943 | 12,116 | I |
| 2026-01-20 | Sale : show line 7 in the form 10b5-1 | −2,456 | $463.26 | $1,137,768 | 9,660 | I |
| 2026-01-20 | Sale : show line 8 in the form 10b5-1 | −2,274 | $464.06 | $1,055,264 | 7,386 | I |
| Open-market sales · 14,625 sh · avg $464.66 · $6,795,627 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-20 | Exercise or conversion : show line 16 in the form 10b5-1 Common Stock | −14,625 | 67,875 | I |
Loading xslF345X05/primarydocument.xml…